Peculiarities of clinical course and rendering surgical care in acute arterial thromboses and spontaneous hematomas on the background of COVID-19
AbstractPresented in the article is a retrospective analysis of treating a total of 36 patients in whom the course of the novel coronavirus infection (COVID-19) was complicated by the development of acute arterial thromboses (23 subjects) and spontaneous hematomas (13 subjects). The course of COVID-19 infection in these patients was regarded as moderate, severe and extremely severe.
Twenty patients with acute thrombosis and six patients with spontaneous hematomas were operated on. The interventions performed were as follows: thrombectomy from arterial segments of lower limbs at various levels, endovascular thromboaspiration, aortic endoprosthetic repair, limb amputation, hematoma drainage. Three patients with acute thrombosis and seven patients with spontaneous hematomas underwent only conservative treatment.
Conclusion. Aggressive surgical policy in acute arterial thrombosis or spontaneous hematoma on the background of a severe course of the novel coronavirus infection is associated with a high but justified risk and a chance for a favorable outcome.
Keywords:COVID-19; thrombohemorrhagic complications; acute thrombosis; spontaneous hematoma; viral vasculitis; endothelial dysfunction
Funding. The study had no financial support.
Conflict of interest. The authors declare no conflict of interest.
Authors’ contribution. Study conception and design – Puzdryak P.D., Shlomin V.V., Erofeev A.A.; data collection and handling – Puzdryak P.D., Ivanov M.A., Samko K.V., Bondarenko P.B., Chistyakova I.G.; statistical processing – Puzdryak P.D., Bondarenko P.B.; draft manuscript preparation – Puzdryak P.D., Shlomin V.V., Gorbunov G.N.; manuscript revision – Puzdryak P.D., Shlomin V.V., Gorbunov G.N., Korovin I.V., Alekseev D.A., Vedernikova E.S., Kasyanov I.V., Didenko Yu.P., Grebenkina N.Yu., Gusinskiy A.V.
For citation: Puzdryak P.D., Shlomin V.V., Gorbunov G.N., Kasyanov I.V., Didenko Yu.P., Grebenkina N.Yu., Erofeev A.A., Ivanov M.A., Samko K.V., Bondarenko P.B., Gusinskiy A.V., Korovin I.V., Alekseev D.A., Vedernikova E.S., Chistyakova I.G. Peculiarities of clinical course and rendering surgical care in acute arterial thromboses and spontaneous hematomas on the background of COVID-19. Angiology and Vascular Surgery. 2022; 28 (4): 51–60. DOI: https://doi.org/10.33029/1027-6661-2022-28-4-51-60 (in Russian)
References
1. Costanzo L., Palumbo F.P., Ardita G., et al. Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2020; 8 (5): 711–716. DOI: https://doi.org/10.1016/j.jvsv.2020.05.018
2. Ilonzo N., Rao A., Safir S., et al. Acute thrombotic manifestations of coronavirus disease 2019 infection: Experience at a large New York City health care system. Journal of Vascular Surgery. 2021; 73 (3): 789–796. DOI: https://doi.org/10.1016/j.jvs.2020.08.038
3. Kozlov I.A., Tyurin I.N. Cardiovascular complications of COVID-19. Messenger of Anesthesiology and Resuscitation. 2020; 17 (4): 14–22. DOI: https://doi.org/10.21292/2078-5658-2020-17-4-14-22
4. WHO Coronavirus Dashboard. 2022. https://COVID19.who.int
5. Dvorakovskaya I.V., Titova O.N., Ariel B.M., et al. Pathological anatomy of vascular lesions in influenza and viral-bacterial pneumonia. Russian Medical Journal. 2021; 29 (3): 3–7. (in Russian)
6. Indes J.E., Koleilat I., Hatch A.N., et al. Early experience with arterial thromboembolic complications in patients with COVID-19. Journal of Vascular Surgery. 2021; 73 (2): 381–389.e1. DOI: https://doi.org/10.1016/j.jvs.2020.07.089
7. Strizheletsky V.V., Yadykin A.A., Ivanov I.G., et al. Spontaneous retroperitoneal hematoma in patients with COVID-19: first clinical experience. Endoscopic Surgery. 2021; 27 (5): 42–47. (in Russian)
8. Ferrario C.M., Jessup J., Chappell M.C., et al. Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2. Circulation. 2005; 111 (20): 2605–2610. DOI: https://doi.org/10.1161/CIRCULATIONAHA.104.510461
9. Varga Z., Flammer A.J., Steiger P., et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395 (10234): 1417–1418. DOI: https://doi.org/10.1016/S0140-6736(20)30937-5
10. Bachinin M.V., Klypa T.V., Mandel I.A. et al. Thrombotic and hemorrhagic complications in patients with severe and extremely severe COVID-19. Russian Journal of Anaesthesiology and Reanimatology. 2022; 24 (2): 24–32. (in Russian)
11. Bonetti P.O., Lerman L.O., Lerman A. Endothelial Dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology. 2003; 23 (2): 168–175. DOI: https://doi.org/10.1161/01.atv.0000051384.43104.fc
12. Mirzoev N.T., Kutelev G.G., Pugachev M.I., Kireeva E.B. Cardiovascular complications in patients after coronavirus DISEASE-2019. Bulletin of the Russian Military Medical Academy. 2022; 24 (1): 199–208. DOI: https://doi.org/10.17816/brmma90733 (in Russian)